<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.66224/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>30</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Design and Mode of Action of a New Synthetic Antibacterial Peptide against Pseudomonas aeruginosa</title>
	<subject_fa> Related Fields</subject_fa>
	<subject>Related Fields</subject>
	<content_type_fa>مقاله کامل</content_type_fa>
	<content_type>Full Length/Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;color:black&quot;&gt;Background: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color:black&quot;&gt;Research into antimicrobial peptides (AMPs) and other novel antimicrobial strategies continues to be a focus of the scientific community to address the growing challenges posed by antibiotic resistance. &lt;/span&gt;The aim of this study was the specific bioinformatic design of a novel hybrid AMP that combines the potent antibacterial properties of Temporins and Brevinin while minimizing its cytotoxic effects. &lt;span style=&quot;color:black&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;color:black&quot;&gt;Methods&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color:black&quot;&gt;: The N-terminal of Brevinin peptides and the C-terminal of Temporin peptide were selected. To optimize the peptide, we replaced the amino acids at positions 1, 3, and 7 with glycine, lysine, and lysine, respectively. Various approaches were used to assess physicochemical characteristics, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), cytotoxicity, apoptosis, hemolytic activity, and &lt;/span&gt;reactive oxygen species&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;color:black&quot;&gt;generation.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;color:black&quot;&gt;Results: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color:black&quot;&gt;The novel peptide had 57% hydrophobicity and four positive electric charges due to its lysine amino acid composition. The synthesized peptide exhibited MIC and MBC values of 80 &amp;micro;M against &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt;. According to the MTT assay, the peptide showed neither cytotoxic nor hemolytic effects on human cells. &lt;/span&gt;The results of electron microscopy showed that this peptide can disrupt the integrity of &lt;i&gt;P. aeruginosa&lt;/i&gt; membrane cells and induce morphological changes in their surface structure.&lt;span style=&quot;color:black&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;This research suggests that the synthetic peptide could serve as a promising potential therapeutic agent to combat antibiotic-resistant strains of &lt;i&gt;P. aeruginosa&lt;/i&gt;. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Antibacterial peptides, Pseudomonas aeruginosa, Temporins, Brevinins</keyword>
	<start_page>81</start_page>
	<end_page>89</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-1944-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Armineh</first_name>
	<middle_name></middle_name>
	<last_name>Azadian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hosseini@yahoo.com</email>
	<code></code>
	<orcid>0009-0000-4845-7868</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>1Department of Biology ،Faculty of Basic Sciences, Islamic Azad University, Science  and Research Branch, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamideh</first_name>
	<middle_name></middle_name>
	<last_name>Mahmoodzadeh Hosseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hosseini361@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-3987-0164</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Applied Microbiology Research Center,  Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences,  Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Ali</first_name>
	<middle_name></middle_name>
	<last_name>Mirhosseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hani@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-4065-7213</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Applied Microbiology Research Center,  Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences,  Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Soghra</first_name>
	<middle_name></middle_name>
	<last_name>Khani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>skhani_22@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-2189-6374</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jafar</first_name>
	<middle_name></middle_name>
	<last_name>Amani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>khan_22@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-5155-4738</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Applied Microbiology Research Center,  Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences,  Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
